UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 445

Sortiert nach

Tuberculosis and Poncet's disease: the many faces of an old enemy

The Lancet (British edition), 2016-02, Vol.387 (10018), p.618-618

Dheda, Keertan, Prof

2016

Volltextzugriff (PDF)

Incipient and Subclinical Tuberculosis: a Clinical Review of Early Stages and Progression of Infection

Clinical microbiology reviews, 2018-10, Vol.31 (4)

2018

Volltextzugriff (PDF)

Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant

The New England journal of medicine, 2021-05, Vol.384 (20), p.1899-1909

2021

Volltextzugriff (PDF)

Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant

The New England journal of medicine, 2021-05, Vol.384 (20), p.1885-1898

2021

Volltextzugriff (PDF)

What is the cost of diagnosis and management of drug resistant tuberculosis in South Africa?

PloS one, 2013-01, Vol.8 (1), p.e54587-e54587

2013

Volltextzugriff (PDF)

Long-term bedaquiline-related treatment outcomes in patients with extensively drug-resistant tuberculosis from South Africa

The European respiratory journal, 2018-05, Vol.51 (5), p.1800544-1800544

2018

Volltextzugriff (PDF)

Global control of tuberculosis: from extensively drug-resistant to untreatable tuberculosis

The lancet respiratory medicine, 2014-04, Vol.2 (4), p.321-338

2014

Volltextzugriff (PDF)

Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults

Cochrane database of systematic reviews, 2021-01, Vol.1 (1), p.CD012768

2021

Volltextzugriff (PDF)

Gamma Interferon Release Assays for Detection of Mycobacterium tuberculosis Infection

Clinical Microbiology Reviews, 2014-01, Vol.27 (1), p.3-20

2014

Volltextzugriff (PDF)

Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis

The Lancet (British edition), 2010-05, Vol.375 (9728), p.1830-1843

2010

Volltextzugriff (PDF)

Genome-wide analysis of multi- and extensively drug-resistant Mycobacterium tuberculosis

Nature genetics, 2018-02, Vol.50 (2), p.307-316

2018

Volltextzugriff (PDF)

Clinical significance of soluble hemoglobin scavenger receptor CD163 (sCD163) in sepsis, a prospective study

PloS one, 2012-07, Vol.7 (7), p.e38400-e38400

2012

Volltextzugriff (PDF)

The intersecting pandemics of tuberculosis and COVID-19: population-level and patient-level impact, clinical presentation, and corrective interventions

The lancet respiratory medicine, 2022-06, Vol.10 (6), p.603-622

2022

Volltextzugriff (PDF)

The global rise of extensively drug-resistant tuberculosis: is the time to bring back sanatoria now overdue?

The Lancet (British edition), 2012-02, Vol.379 (9817), p.773-775

2012

Volltextzugriff (PDF)

Supervised and unsupervised self-testing for HIV in high- and low-risk populations: a systematic review

PLoS medicine, 2013-04, Vol.10 (4), p.e1001414-e1001414

2013

Volltextzugriff (PDF)

Do high rates of empirical treatment undermine the potential effect of new diagnostic tests for tuberculosis in high-burden settings?

The Lancet infectious diseases, 2014-06, Vol.14 (6), p.527-532

2014

Volltextzugriff (PDF)

Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial

The Lancet (British edition), 2014-02, Vol.383 (9915), p.424-435

2014

Volltextzugriff (PDF)

A comparison of the conditional inference survival forest model to random survival forests based on a simulation study as well as on two applications with time-to-event data

BMC medical research methodology, 2017-07, Vol.17 (1), p.115-115, Article 115

2017

Volltextzugriff (PDF)

Same-Day Tools, Including Xpert Ultra and IRISA-TB, for Rapid Diagnosis of Pleural Tuberculosis: a Prospective Observational Study

Journal of clinical microbiology, 2019-09, Vol.57 (9)

2019

Volltextzugriff (PDF)

Bacterial and host determinants of cough aerosol culture positivity in patients with drug-resistant versus drug-susceptible tuberculosis

Nature medicine, 2020-09, Vol.26 (9), p.1435-1443

2020

Volltextzugriff (PDF)

Evaluation of the Xpert MTB/RIF Assay for the Diagnosis of Pulmonary Tuberculosis in a High HIV Prevalence Setting

American journal of respiratory and critical care medicine, 2011-07, Vol.184 (1), p.132-140

2011

Volltextzugriff (PDF)

Linezolid interruption in patients with fluoroquinolone-resistant tuberculosis receiving a bedaquiline-based treatment regimen

International journal of infectious diseases, 2019-08, Vol.85, p.74-79

2019

Volltextzugriff (PDF)

Comparison of Xpert MTB/RIF (G4) and Xpert Ultra, including trace readouts, for the diagnosis of pulmonary tuberculosis in a TB and HIV endemic setting

International journal of infectious diseases, 2020-06, Vol.95, p.246-252

2020

Volltextzugriff (PDF)

1 – 25 von 445

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(423)
Mit Volltextzugriff
(414)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(330)
Humans
(270)
Life Sciences & Biomedicine
(259)
Tuberculosis
(218)
Male
(119)
Adult
(117)
Infectious Diseases
(117)
Female
(112)
Mycobacterium Tuberculosis
(91)
Respiratory System
(90)
Hiv
(86)
Human Immunodeficiency Virus
(83)
Infections
(78)
Drug Resistance
(73)
General & Internal Medicine
(73)
Middle Aged
(72)
Patients
(72)
Science & Technology - Other Topics
(71)
Multidisciplinary Sciences
(70)
Tuberculosis - Diagnosis
(62)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Tuberculosis and Poncet's disease: the many faces of an old enemy

Incipient and Subclinical Tuberculosis: a Clinical Review of Early Stages and Progression of Infection

Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant

Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant

What is the cost of diagnosis and management of drug resistant tuberculosis in South Africa?

Long-term bedaquiline-related treatment outcomes in patients with extensively drug-resistant tuberculosis from South Africa

Global control of tuberculosis: from extensively drug-resistant to untreatable tuberculosis

Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults

Gamma Interferon Release Assays for Detection of Mycobacterium tuberculosis Infection

Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis

Genome-wide analysis of multi- and extensively drug-resistant Mycobacterium tuberculosis

A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis

Clinical significance of soluble hemoglobin scavenger receptor CD163 (sCD163) in sepsis, a prospective study

The intersecting pandemics of tuberculosis and COVID-19: population-level and patient-level impact, clinical presentation, and corrective interventions

The global rise of extensively drug-resistant tuberculosis: is the time to bring back sanatoria now overdue?

Supervised and unsupervised self-testing for HIV in high- and low-risk populations: a systematic review

Do high rates of empirical treatment undermine the potential effect of new diagnostic tests for tuberculosis in high-burden settings?

Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial

A comparison of the conditional inference survival forest model to random survival forests based on a simulation study as well as on two applications with time-to-event data

Effect on mortality of point-of-care, urine-based lipoarabinomannan testing to guide tuberculosis treatment initiation in HIV-positive hospital inpatients: a pragmatic, parallel-group, multicountry, open-label, randomised controlled trial

Same-Day Tools, Including Xpert Ultra and IRISA-TB, for Rapid Diagnosis of Pleural Tuberculosis: a Prospective Observational Study

Bacterial and host determinants of cough aerosol culture positivity in patients with drug-resistant versus drug-susceptible tuberculosis

Evaluation of the Xpert MTB/RIF Assay for the Diagnosis of Pulmonary Tuberculosis in a High HIV Prevalence Setting

Linezolid interruption in patients with fluoroquinolone-resistant tuberculosis receiving a bedaquiline-based treatment regimen

Comparison of Xpert MTB/RIF (G4) and Xpert Ultra, including trace readouts, for the diagnosis of pulmonary tuberculosis in a TB and HIV endemic setting

Suchergebnisse filtern